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The Toll-like receptors (TLRs) of the innate immune
system are unusual in that individual family members
are located on different organelles, yet most activate
a common signaling pathway important for host de-
fense. It remains unclear how this common signaling
pathway can be activated from multiple subcellular
locations. Here, we report that, in response to natural
activators of innate immunity, the sorting adaptor
TIRAP regulatesTLRsignaling from theplasmamem-
brane and endosomes. TLR signaling fromboth loca-
tions triggers the TIRAP-dependent assembly of the
myddosome, a protein complex that controls proin-
flammatory cytokine expression. The actions of
TIRAP depend on the promiscuity of its phosphoino-
sitide-binding domain. Different lipid targets of this
domain direct TIRAP to different organelles, allowing
it to survey multiple compartments for the presence
of activated TLRs. These data establish how promis-
cuity, rather than specificity, can be a beneficial
means of diversifying the subcellular sites of innate
immune signal transduction.
INTRODUCTION
At some point in their existence, all proteins must move within
mammalian cells. Some movement is biosynthetic, in that the
protein must be transported from its site of synthesis on the ribo-
some to its site of action. Another type of movement is signal
dependent, meaning that the protein will move from one location
to another in response to some cellular stimulus. Classic cell bio-
logical studies identified the cis-acting sequences that direct
these types of protein movement within cells, for example,
Blobel and Dobberstein (1975a, 1975b) and Baeuerle and Balti-more (1988). In addition to these examples, amore complex type
of protein movement exists, where proteins can be found in
multiple locations under resting conditions or can be recruited
to multiple locations in response to a stimulus. In this latter
instance, it is not obvious how a single localization signal would
allow a protein to be targeted to (and function from) multiple
organelles. An example of this can be found from the studies
of the Toll-like receptors (TLRs) of the innate immune system.
TLRs are transmembrane receptors that are expressed by a
variety of mammalian cell types but are best studied in profes-
sional phagocytes such as macrophages and dendritic cells
(DCs) (Akira et al., 2006). TLRs detect a wide range of microbial
products andmay be divided into different groups based on their
subcellular site of ligand recognition (Barton and Kagan, 2009).
TLRs 1, 2, and 4–6 reside at the plasma membrane, where
they detect molecules displayed on the surface of various path-
ogens. TLRs 3, 7–9, and 11–13 are localized to various endoso-
mal compartments, where most detect microbial nucleic acids.
Despite residing in distinct subcellular compartments, most
TLRs activate a common signal transduction pathway to induce
innate and adaptive immunity. TLR signaling usually initiates with
the activation of an adaptor protein called MyD88, which is
recruited to the conserved TIR domain present in the cytosolic
tail of all receptors of this family (Gay et al., 2011; O’Neill and
Bowie, 2007). MyD88 forms a protein complex with kinases of
the IRAK family called the myddosome (Lin et al., 2010; Motsh-
wene et al., 2009). This complex is thought to induce a cascade
of signaling events that activates the NF-kB-dependent expres-
sion of cytokines, chemokines, and other immunomodulatory
factors (Gay et al., 2011; Motshwene et al., 2009; Medzhitov
and Horng, 2009). Because TLRs reside on distinct organelles,
the myddosome must have the capacity to be assembled in
multiple subcellular locations. How myddosome assembly can
be promoted from multiple locations is unknown. Answering
this question will fill a fundamental gap in our understanding of
how immune signaling pathways are integrated into the cellular
infrastructure within which they operate.Cell 156, 705–716, February 13, 2014 ª2014 Elsevier Inc. 705
A simple explanation for how MyD88 can be recruited to
diverse organelles would be through interactions with the TIR
domains of activated TLRs. However, two-hybrid analyses per-
formed in yeast and mammalian cells indicated that MyD88
has limited ability to interact with TLRs directly (Brown et al.,
2006; Ulrichts et al., 2007). For this reason, an intermediate pro-
tein is likely required to link activated TLRs to the recruitment of
MyD88. Consistent with this model, the cell-surface TLRs utilize
‘‘sorting adaptors’’ to accomplish this task. Sorting adaptors are
the only regulators of TLR signaling that are located at the sub-
cellular site of signal transduction, prior to any microbial
encounter (Kagan, 2012a). Their placement at the eventual site
of signaling allows sorting adaptors to function as sensors of
activated TLRs and recruit downstream signaling adaptors
(e.g., MyD88) to induce inflammatory cytokine expression.
Most plasma membrane-localized TLRs use the sorting adaptor
TIRAP (also known as Mal) to recruit MyD88 to the cell surface
(Fitzgerald et al., 2001; Horng et al., 2002; Kagan andMedzhitov,
2006; Yamamoto et al., 2002). The ability of TIRAP to function as
a sorting adaptor is dependent on its amino-terminal localization
domain, which interacts with plasma membrane-localized phos-
phatidylinositol-4,5 bisphosphate (PI(4,5)P2) and other lipids
(Kagan and Medzhitov, 2006). The use of sorting adaptors
extends beyond theMyD88-dependent pathways because anal-
ogous systems exist in other immune signaling pathways in
mammals and Drosophila melanogaster (Kagan, 2012a; Kagan
et al., 2008; Marek and Kagan, 2012).
Despite the apparent importance of sorting/signaling adaptor
pairs for controlling TLR signaling from the cell surface, a
sorting adaptor for the exclusively endosomal TLRs has not
been described. As such, it is unclear how MyD88-dependent
innate immune responses are activated by endosomal TLRs.
TIRAP was initially excluded as a sorting adaptor for endoso-
mal TLRs because TIRAP-deficient cells retain the ability to
respond to synthetic TLR7 and TLR9 ligands (Horng et al.,
2002; Yamamoto et al., 2002). However, these studies also
demonstrated that the requirement of TIRAP for signaling
from cell-surface-localized TLRs can be bypassed when high
concentrations of ligand are used. Primary macrophages and
DCs are highly endocytic. This property, combined with the
common use of phosphorothioate-linked (nuclease-resistant)
nucleic acids to activate endosomal TLRs, led us to hypothe-
size that these ligands could accumulate to high concentra-
tions within endosomes, masking a requirement for TIRAP. In
light of this hypothesis, we decided to reassess the role of
TIRAP in endosomal TLR signaling.
Herein, we report that TIRAP is required for signaling down-
stream of endosomal TLRs in response to natural ligands, such
as viral nucleic acids. We show that TIRAP is present in
myddosomes induced by both cell-surface and endosomal
TLRs and is required for myddosome formation. Furthermore,
we show that the ability of TIRAP to bind to multiple lipid
species is critical for its ability to function from multiple sub-
cellular compartments. These findings provide a molecular
explanation for the ability of MyD88 to be recruited to more
than one organelle and highlight how a promiscuous lipid-
binding domain can be used to diversify the subcellular sites
of innate immune signal transduction.706 Cell 156, 705–716, February 13, 2014 ª2014 Elsevier Inc.RESULTS
TIRAP Is Required for Endosomal TLR Signaling in
Response to Viral Infection
To determine whether TIRAPwould function as a sorting adaptor
for endosomal TLRs, we readdressed the genetic requirement
for this protein in the signaling pathway activated by TLR9.
TLR9 is an excellent model for these studies for two reasons.
First, it is the best-characterized endosome-localized TLR
(Barbalat et al., 2011), and its ligand (unmethylated CpG-
containing DNA) is easy to produce (Hemmi et al., 2000).
Second, whereas several viruses activate TLRs at the cell
surface and endosomes (Barbalat et al., 2009; Georgel et al.,
2007; Kurt-Jones et al., 2004), substrains of herpes simplex virus
(HSV) exist that only activate TLR9 (Sato et al., 2006). Thus, TLR9
provides a useful model for the study of both synthetic (CpG
DNA) and natural (HSV) activators of endosomal TLRs.
Wild-type (WT) and TIRAP knockout (KO) primary bone-
marrow-derived macrophages (BMDMs) were stimulated with
CpG DNA or three substrains of HSV-1 (Sato et al., 2006). The
cell populations were then assessed for the expression of the
cytokines interleukin-1b (IL-1b) and IL-6. As expected (Horng
et al., 2002; Yamamoto et al., 2002), TIRAP KO BMDMs had
no defect in responding to CpG DNA, whereas their response
to bacterial lipopolysaccharide (LPS), a ligand for the cell-
surface TLR4, was impaired (Figure 1A). Interestingly, whereas
all three substrains of HSV induced the expression of IL-1b
and IL-6 in WT BMDMs, TIRAP KO BMDMs were defective for
these responses (Figure 1B). Among the HSV substrains tested,
Kos A and Kos CE only engage TLR9, whereas Kos K engages
both cell-surface TLR2 and endosomal TLR9 (Sato et al.,
2006). Our finding that TIRAP is required for cytokine expression
in response to HSV substrains that only engage TLR9 suggests
that this adaptor plays a role in signaling from endosomal
receptors. Interestingly, as was observed for ligands that acti-
vate cell-surface-localized TLRs (Horng et al., 2002), the require-
ment for TIRAP in TLR9 signaling can be bypassed by increasing
the dose of a subset of HSV substrains (Figure S1A available
online, multiplicity of infection [moi] = 10). The requirement of
TIRAP for antiviral responses was unique to the TLR pathway
because WT and TIRAP KO BMDMs expressed the interferon
(IFN)-inducible gene viperin comparably when infected with
mammalian reovirus (Figure S1B), a known activator of the cyto-
solic RIG-I-like receptors (Dixit et al., 2010). Collectively, these
data suggest an important role of TIRAP in the response to
natural (viral) activators of endosomal TLR9.
To corroborate these findings, we sought an alternative cell
type to study the role of TIRAP. Plasmacytoid DCs (pDCs) are
an intriguing option because they exclusively utilize endosomal
TLRs to detect infections (Gilliet et al., 2008). As such, all of the
plasma membrane-localized TLRs that are established to
require TIRAP are nonfunctional in these cells (Sato et al.,
2006). Moreover, in pDCs, endosomal TLRs exhibit an
intriguing behavior in that they can induce cytokine and IFN
production from different populations of endosomes, with
IFN production occurring from endosomes rich in 30 phosphoi-
nositides (PIs) (Sasai et al., 2010). We reasoned that if TIRAP
was not required for endosomal TLR signaling, as previously
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Figure 1. TIRAP Is Required for Endosomal
TLR Signaling in Response to Natural
Ligands
(A and B) Primary WT or TIRAP KO BMDMs were
treated with 100 ng/ml LPS or 1 mM CpG DNA (A)
or infected with HSV (B) for 3 hr. Total mRNA was
extracted and analyzed for expression of IL-1b and
IL-6. Note that TIRAP KO BMDMs are defective in
responding to natural ligands. N.S., cells that were
not stimulated.
(C)Microarraygeneexpressionprofiles fromsorted
cDCs and pDCs were analyzed for transcripts
associated with TLR signaling pathways. Values on
the x axis represent the fold difference in gene
expression between mDCs and pDCs. Gray area
depicts equal gene expression in cDCs and pDCs.
Note that TIRAP is expressed in pDCs comparably
to cDCs, despite the absence of cell-surface TLRs.
(D) pDCs from WT or TIRAP KO mice were
infected with HSV-2 (186 syn+) at an moi of 1 or
influenza (A/PR/8) at an moi of 10. Supernatants
were collected after 24 hr and analyzed by ELISA.
Error bars represent SD. See also Figure S1.reported by Horng et al. (2002) and Yamamoto et al. (2002),
then pDCs would have no need to express the gene encoding
this adaptor. To address this possibility, a comparison of gene
expression was performed between highly purified pDCs and
conventional DCs (cDCs). This analysis revealed that pDCs ex-
press much lower levels of the cell-surface TLRs 1, 2, 4, and 6
than cDCs (Figure 1C). This observation may (in part) explain
the inability of pDCs to respond to ligands for plasma mem-
brane-localized TLRs (Sato et al., 2006). pDCs expressed
higher levels of some endosomal TLRs (TLR7 and TLR12)
than their cDC counterparts. Interestingly, both cell types ex-
pressed comparable levels of TLR9, TIRAP, and MyD88 (Fig-
ure 1C), suggesting that TIRAP may indeed have a function
downstream of endosomal TLRs in pDCs. To address this pos-
sibility, pDCs were infected with either HSV or influenza virus,
natural activators of endosomal TLR9 and TLR7, respectively
(Diebold et al., 2004; Lund et al., 2004). Infected cells were
then assessed for their ability to induce the expression of
IFNa or the cytokine IL-12p40. Because the expression of
these cytokines is initiated from different populations of endo-
somes (Sasai et al., 2010), this experiment allows us to deter-
mine if a population of endosomes exists that selectively
requires TIRAP function. In comparison to WT pDCs, TIRAP
KO pDCs were impaired in the ability to produce IFNa in
response to HSV or influenza virus (Figure 1D). In contrast,
the production of IL-12p40 was not impaired in TIRAP KOCell 156, 705–716,pDCs, suggesting that TIRAP regulates
signaling from endosomes that were
previously defined as being rich for 30
PIs (Sasai et al., 2010). Another sorting
adaptor may exist to control TLR
signaling to induce IL-12p40. Overall,
these data establish that, in response
to natural activators of innate immunity,
TIRAP is required for signaling by endo-somal TLRs in multiple cell types. Furthermore, the use of HSV
strains that only activate TLR9, and the use of pDCs that only
permit signaling by endosomal TLRs, eliminates the possibility
of contaminating bacterial products (e.g., LPS) explaining
these observations.
Immortalized Macrophages Are a Model for
Investigating Endosomal TLR Signaling
To define the means by which TIRAP regulates TLR signaling
from multiple organelles, we sought a cell type that would be
easy to propagate and amenable to genetic manipulation.
Immortalized BMDMs (iBMDMs) have emerged as a useful
tool in this regard because they retain the signaling properties
of their primary cell counterparts (Dixit et al., 2010; Halle et al.,
2008), and TIRAP KO iBMDMs have been used to dissect the
functions of this adaptor (Nagpal et al., 2009). Similar to our
observations made in primary BMDMs, TIRAP was required
for iBMDMs to respond to several substrains of HSV, including
two that engage only TLR9 (Kos A and Kos CE) (Figure 2A)
(Sato et al., 2006). We found that iBMDMs are less phagocytic
than primary BMDMs (Figure 2B). This was expected because
endocytosis and phagocytosis rates are higher in nonmitotic
macrophages (e.g., primary BMDMs) than in dividing macro-
phages (Berlin et al., 1978). We hypothesized that this lower
phagocytic activity would prevent CpG DNA from building to
high concentrations within endosomes, perhaps revealing aFebruary 13, 2014 ª2014 Elsevier Inc. 707
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Figure 2. iBMDM Responses to CpG DNA
Mimic Primary Cell Responses to Natural
Ligands
(A) WT, TIRAP KO, or TIRAP-expressing TIRAP KO
iBMDMs were infected with indicated HSV strains
(moi = 1) for 3 hr and analyzed by qPCR.
(B) Primary or iBMDMs were incubated with fluo-
rescent beads at 37C for the indicated times, and
phagocytosis was analyzed by flow cytometry.
Mean fluorescence intensity was plotted relative to
cells incubated with beads on ice for 45 min.
(C) WT or TIRAP KO primary and iBMDMs were
stimulated with 1mM CpG DNA. After 24 hr,
supernatants were collected and analyzed for IL-6
by ELISA. N.D., no signal was detected.
(D)WT, TIRAP KO, or TIRAP-expressing TIRAP KO
iBMDMs were treated with LPS or CpG DNA for
3 hr and analyzed by qPCR.
Error bars represent SD. See also Figure S1.requirement for TIRAP in responses to synthetic TLR9 ligands.
Indeed, whereas WT iBMDMs responded to CpG DNA compa-
rably to primary WT BMDMs, TIRAP KO iBMDMs were
completely unresponsive (Figure 2C). However, high doses of
CpG DNA partially overcame the requirement for TIRAP in
these cells (Figure S1C). To determine whether TIRAP defi-
ciency was responsible for the unresponsiveness of these cells
to TLR9 ligands, this adaptor was stably reintroduced into
TIRAP KO iBMDMs via retroviral transduction. The retroviral
vector used also encodes an internal ribosomal entry site
upstream of EGFP, which allowed for the use of fluores-
cence-activated cell sorting (FACS) to isolate a population of
cells with uniform levels of expression (data not shown).
Rescuing TIRAP expression in TIRAP KO iBMDMs restored
responsiveness to plasma membrane and endosomal-local-
ized TLR ligands (Figure 2D). Furthermore, rescuing TIRAP
expression enabled an enhanced response to all substrains
of HSV examined (Figures 2A and S1D). Among the substrains
examined is HSV-7134 (Figure S1D), which lacks the expres-
sion of ICP0 (van Lint et al., 2010). ICP0 is an immune evasion
protein that may interfere with TLR signaling by causing the
degradation of TIRAP and/or MyD88 (van Lint et al., 2010).
To determine whether ICP0 is acting to prevent TLR signaling
in our assays, side-by-side experiments were performed with
HSV-7134 and an isogenic substrain whose expression of
ICP0 was restored (7134R). We observed no difference in the
ability of these strains to induce TIRAP-dependent cytokine
expression (Figure S1D). These data suggest that ICP0 may708 Cell 156, 705–716, February 13, 2014 ª2014 Elsevier Inc.act at a later stage of infection or in a
different cell type to interfere with TLR
signaling. Overall, the observation that
the signaling defects of TIRAP KO cells
can be rescued by the expression of a
TIRAP cDNA provides formal genetic
proof of its role in signal transduction
activated by endosomal TLRs. iBMDMs
therefore provide a genetically tractable
model to study the role of TIRAP insignaling from endosomal TLRs through the use of natural
and synthetic ligands.
TIRAP Promotes the Assembly of Myddosomes at the
Plasma Membrane and Endosomes
Based on the experiments described above, it was possible
that TIRAP acts to assemble myddosomes after activation of
TLRs found at the plasma membrane and endosomes. The
crystal structure of the myddosome indicates that the adaptor
MyD88 is a core component of this signaling complex (Lin
et al., 2010). However, the natural kinetics of myddosome
assembly induced by TLR ligands remains undefined. To
assess myddosome assembly, iBMDMs were stimulated with
LPS or CpG DNA, and endogenous MyD88 immunoprecipitates
were subjected to western analysis for the presence of the other
known components of the myddosome, the kinases IRAK2 and
IRAK4 (Lin et al., 2010; Motshwene et al., 2009). Within minutes
of stimulating cells with either LPS or CpG DNA, both kinases
were recruited to MyD88 (Figures 3A and 3B). Immunoprecipita-
tions with IRAK2 antisera yielded comparable results, with
MyD88 and IRAK4 being recruited to IRAK2 within minutes of
stimulation (Figure S2A). Consistent with prior work on the acti-
vation of MAP kinases and NF-kB (Horng et al., 2002; Schnare
et al., 2000), LPS induced maximal assembly of the myddo-
some more rapidly than CpG DNA (Figures 3A and 3B).
Because the myddosome is not detected in resting cells, its
assembly can be used to monitor the earliest cytosolic events
that occur during TLR signaling.
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Figure 3. TIRAP Is a Critical Constituent of
the Myddosome
(A and B) WT iBMDMswere stimulated with LPS (A)
or CpGDNA (B) for the indicated times. MyD88 was
immunoprecipitated (IP) from lysates and analyzed
by western blot.
(C and D) TIRAP-transgenic iBMDMs were stimu-
lated with LPS (C) or CpG DNA (D), and biotin-
TIRAP was precipitated from cleared lysates with
avidin-coated agarose before western analysis.
(E) WT, TIRAP KO, or TIRAP-expressing TIRAP KO
iBMDMswere treatedwith LPS for 1 hr or CpGDNA
for 2 hr and analyzed as in (A). N.S., cells that were
not stimulated.
See also Figure S2.To determine whether TIRAP is a component of LPS or CpG
DNA-induced myddosomes, we utilized the transgenic TIRAP
KO cells described above. The TIRAP allele expressed in these
cells contains a biotinylation sequence and an HA epitope tag
to facilitate biochemical analysis. LPS and CpG DNA-induced
myddosomes containing IRAK4 and MyD88 could be detected
by direct isolation of biotinylated TIRAP through the use avidin-
coated beads (Figures 3C and 3D). Moreover, TIRAP could be
recruited to MyD88 immunoprecipitates in LPS-treated cells
(Figure S2B). These data indicate that TIRAP is a stable compo-
nent of the myddosomes induced by either TLR4 or TLR9.
To determine whether TIRAP was required for myddosome
formation, TIRAP KO iBMDMs were examined. Myddosome for-
mation in response to both LPS and CpG DNA was impaired in
TIRAP KO cells but rescued in TIRAP KO cells expressing the
TIRAP transgene (Figure 3E). These data establish that TIRAP
controls the assembly of (and is a component of) myddosomes
formed in multiple subcellular compartments.
Promiscuous Lipid Binding Diversifies the Subcellular
Sites of TIRAP Residence
TIRAP is a peripheral membrane protein that is enriched at the
cell surface (Kagan and Medzhitov, 2006). Our discovery that
TIRAP regulates TLR signaling from endosomes therefore raisesCell 156, 705–716the question of how a plasma membrane-
localized adaptor can function from endo-
somes. The localization of TIRAP is strictly
dependent on an amino-terminal lipid-
binding domain that interacts with acidic
PIs and phosphatidylserine (PS) (Kagan
and Medzhitov, 2006). To confirm these
observations, the ability of TIRAP to bind
lipids was assessed by PIP-strip analysis,
which permits the identification of several
possible protein-lipid interactions in a
single experiment. Glutathione S-trans-
ferase (GST)-TIRAP interacted with all
phosphorylated PIs and PS (Figure 4A).
As a control for specificity of these interac-
tions, we used a mutant that is defective
for lipid binding in vitro and localization
in vivo (TIRAP 4X) (Kagan and Medzhitov,2006). This mutant TIRAP allele did not bind to any lipids in this
analysis (Figure 4A). Among the lipids TIRAP interacts with,
PI(4,5)P2 is considered solely important for its function in con-
trolling signaling by plasma membrane-localized TLRs (Aksoy
et al., 2012; Kagan and Medzhitov, 2006). In this regard, TIRAP
is similar to many other lipid-binding proteins in that its ability
to bind PIs promiscuously is not considered functionally signifi-
cant (Kavran et al., 1998).
Because some of the lipids that TIRAP interacts with are
enriched on endosomes (e.g., PI(3)P and PI(3,5)P2) (De Matteis
and Godi, 2004), we considered the possibility that a pool of
TIRAP would be located on endosomes. This possibility was
addressed by examining the localization of the lipid-binding
domain of TIRAP in primary BMDMs. We transfected these cells
with plasmids encoding the GFP-tagged lipid-binding domain of
TIRAP (TIRAP-loc) along with a plasmid encoding a cherry-
tagged pleckstrin homology (PH) domain from PLCd1 (PLC),
which binds to PI(4,5)P2 uniquely (Botelho et al., 2000). We
reasoned that, if TIRAP binds only to PI(4,5)P2 within cells,
then the subcellular distribution of these two proteins should
be identical. However, if TIRAP binds to more lipids than
PI(4,5)P2, then the distributions of these proteins should be over-
lapping but distinct. Confocal microscopy revealed that both
proteins colocalized extensively at the plasmamembrane, which, February 13, 2014 ª2014 Elsevier Inc. 709
Figure 4. Promiscuous Lipid Binding Diversifies the Localization of TIRAP
(A) GST-tagged TIRAP or TIRAP 4X proteins were incubated with PIP strips containing various lipids (shown in left panel) and assessed for protein binding by far
western analysis.
(B) TIRAP KO primary BMDMs expressing TIRAP loc-GFP and PLC-cherry were analyzed by confocal microscopy. All images are representative of at least three
independent experiments where more than 200 cells were examined per condition and >95% of the cells displayed similar staining. Selective localization of
TIRAP to intracellular vesicles compared to the PLCd1 PH domain demonstrates that TIRAP binds to multiple lipids.
(C) TIRAP KO primary BMDMs expressing TIRAP loc-GFP were analyzed by confocal microscopy. One image was captured every 20 s for 20 min. (C) Shows
representative frames from one such capture (see Movie S1 for full-length movie).
See also Movie S1.
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is an abundant site of PI(4,5)P2 (Botelho et al., 2000). Interest-
ingly, TIRAP’s lipid-binding domain also labeled intracellular
vesicles that were devoid of the PLCd1 PH domain (Figure 4B,
inset), suggesting that TIRAP binds additional lipid targets inside
cells, as it does in vitro.
To determine whether the intracellular TIRAP-positive com-
partments were endosomes, live time-lapse microscopy was
performed in primary BMDMs expressing the GFP-tagged
lipid-binding domain of TIRAP. Primary BMDMs were highly
active and exhibited extensive ruffling of the plasma membrane
(Movie S1). Numerous TIRAP-positive vesicles were formed at
these sites of membrane ruffling, and these vesicles accumu-
lated Alexa-647-labeled dextrans that were added to the culture
media shortly after imaging began (Figure 4C; Movie S1). These
data indicate that the lipid-binding domain of TIRAP is capable of
localizing to the plasma membrane and bona fide endosomes.
Promiscuous lipid binding by TIRAP may therefore be important
for its ability to function as a sorting adaptor for TLRs located at
the cell surface and endosomes.
Distinct Lipid Targets of the TIRAP Localization Domain
Permit TLR Signaling from the Plasma Membrane and
Endosomes
To determine the function of the individual lipids with which
TIRAP interacts, the lipid-binding domain of TIRAP was replaced
with domains of singular specificity (Figure 5A, top). We replaced
the endogenous lipid-binding domain of TIRAP with the PLCd1
PH domain described above, which binds exclusively to PI(4,5)
P2 (hereafter referred to as PLC-TIRAP). By a similar strategy,
a PI(3)P-specific TIRAP allele was generated called PX-TIRAP.
This adaptor has the localization domain of p40-phox, which
binds exclusively to PI(3)P on endosomes (Kagan and Medzhi-
tov, 2006; Sato et al., 2001). PX-TIRAP was of particular interest
because of our finding that TIRAP preferentially regulates IFNa
expression induced by TLR7 and TLR9 (Figure 1D), which occurs
from endosomes containing 30 PIs in pDCs (Sasai et al., 2010).
Finally, SLP2a-TIRAP was generated, which binds PS, a general
component of the cell surface and endosomal membranes (Kur-
oda and Fukuda, 2004). These constructs were fused to GFP,
stably transduced into TIRAP KO iBMDMs, and subjected to
FACS to isolate clones of comparable expression levels. The
resulting cell populations were examined by confocal micro-
scopy, which verified their expected localization (Figure 5A,
bottom). PLC-TIRAP was detected primarily at the cell surface,
PX-TIRAP was enriched on intracellular vesicles previously iden-
tified as endosomes (Kagan and Medzhitov, 2006), and SLP2a-
TIRAP was detected at the cell surface and endosomes.
This set of stable macrophage lines was stimulated with LPS
or CpG DNA to determine which lipids were important for TLR
signal transduction. As expected, TIRAP KO cells expressing
WT TIRAP regained the ability to permit TLR4 signaling from
the cell surface and TLR9 signaling from endosomes (Figure 5B).
The cell-surface-exclusive PLC-TIRAP restored responsiveness
to the TLR4 ligand LPS, but interestingly, this allele did not
restore TLR9 signaling in response to CpG DNA (Figure 5B).
These data indicate that whereas PI(4,5)P2 binding by TIRAP is
sufficient for signaling from the plasma membrane, it is not
sufficient for signaling from endosomes. Remarkably, examina-tion of the function of PX-TIRAP yielded the opposite results.
TIRAP KO cells expressing PX-TIRAP (localized to endosomes
via PI(3)P) responded robustly to CpG DNA but did not respond
to LPS (Figure 5B). Similar results were obtained with the PS-
binding SLP2a-TIRAP allele (Figure 5B).
The localization of TIRAP was also critical for myddosome
formation. Consistent with Figure 3E, TIRAP KO cells reconsti-
tuted with WT TIRAP formed myddosomes in response to both
LPS and CpG DNA (Figure 5C). By contrast, PLC-TIRAP was
able to rescue myddosome formation solely in response to
LPS, whereas PX-TIRAP and SLP2a-TIRAP were able to rescue
myddosome formation in response to CpG DNA, but not LPS
(Figure 5C). Overall, these data establish that distinct targets of
the promiscuous TIRAP lipid-binding domain are functional
and allow this adaptor to promote TLR signaling from more
than one site in the cell.
DISCUSSION
It has become clear in recent years that TLRs can induce signal
transduction from diverse locations in the cell, with the cell sur-
face and endosomal membranes being the best-defined sites
(Kagan, 2012b). However, the question remained as to how
this diversification of receptor locale can be accommodated
with the common need to activate MyD88-dependent signaling.
Our finding that TIRAP can function as a sorting adaptor for
MyD88 at the cell surface and endosomes provides a molecular
explanation to this question and fills an important gap in our
knowledge of how diverse subcellular compartments can sup-
port TLR signaling.
Several lines of evidence indicate that TIRAP can function from
endosomes. First, TIRAP KO primary and immortal BMDMs are
defective for TLR signaling in response to HSV infection. This
finding is in contrast to results obtained with nondegradable
nucleic acids containing phosphorothioate linkages, which
bypass the need for TIRAP in primary BMDMs. These data high-
light the utility of natural activators of innate immunity to dissect
TLR signal transduction pathways. Second, TIRAP is expressed
in cells that do not express plasma membrane-localized TLRs
(pDCs), and TIRAP KO pDCs are defective for IFN responses
induced by TLR7 or TLR9. Because plasma membrane-localized
TLRsarenot functional in pDCs, thesedata eliminate anypossibil-
ity that contaminating TLR2 or TLR4 ligands can explain our find-
ings. Third, TIRAP is a component of myddosomes induced by
TLR4 and TLR9 and is required for their formation. Collectively,
usingmultipleactivators, assays, andcell types, thesedataestab-
lish that TIRAP has a widespread role in controlling TLR signal
transduction in response to bacteria and viruses (Figure 5D).
We do note, however, that not all MyD88-dependent re-
sponses are mediated by TIRAP. In addition to the MyD88-
dependent signaling pathways activated by the IL-1 receptor
(IL-1R) family (Horng et al., 2002; Yamamoto et al., 2002), we
found that TLR7/TLR9-induced IL-12p40 expression in pDCs
was TIRAP independent. This finding is in contrast to TLR7/
TLR9-induced IFNa expression in the same cells. Thus, like
TLR4 (Kagan, 2012a), at least some endosomal TLRs may
engage distinct sorting adaptors to induce compartment-
specific cellular responses. The sorting adaptor(s) that mediatesCell 156, 705–716, February 13, 2014 ª2014 Elsevier Inc. 711
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Figure 5. Promiscuous Lipid Binding by TIRAP Diversifies the Sites of TLR Signaling
(A) Confocal microscopic analysis of TIRAP KO iBMDMs stably transduced with GFP-tagged TIRAP alleles that contain different lipid-binding domains (depicted
in the top panel). The micrographs demonstrate selective localization of TIRAP dependent on its lipid-binding domain. All images are representative of at least
three independent experiments where over 200 cells were examined per condition and >95% of the cells displayed similar staining.
(B) Cells from (A) were stimulated with LPS or CpG DNA and analyzed by qPCR. Note that selective binding of TIRAP to distinct lipids permits signaling from
distinct compartments.
(C) Cells from (A) were stimulated with LPS or CpG DNA for 1 hr, and myddosome formation was assessed.
(D) Model depicting how the promiscuous lipid-binding domain of TIRAP promotes signal transduction from the plasma membrane and endosomes. TLRs found
at the cell surface signal from a PI(4,5)P2-rich subdomain, and TIRAP is recruited to that location via interactions with PI(4,5)P2. TLRs found on endosomes signal
from a domain rich in 30 PIs (depicted is PI(3)P). These lipids direct TIRAP to endosomes to promote TLR signaling.
Error bars represent SD.
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MyD88 recruitment to these TIRAP-independent receptors
remains unknown. An alternative explanation for these observa-
tions is that endosomes that induce IL-12p40 expression may
contain higher concentrations of TLR ligands than IFN-inducing
endosomes, rending some signaling pathways more dependent
on TIRAP than others. Although it is formally possible that some
TLRs simply recruit MyD88 to their cytosolic TIR domains
directly (bypassing the need for a sorting adaptor), the increasing
incidence of sorting adaptor dependence for MyD88 recruitment
makes this possibility unlikely.
TIRAP is one of numerous PI-binding proteins that can bind to
multiple lipids (Kavran et al., 1998). This promiscuity of lipid bind-
ing has been a point of inquiry because we and others have
suggested that PI(4,5)P2 is mainly responsible for controlling
its localization and function (Aksoy et al., 2012; Kagan andMedz-
hitov, 2006). Our finding that a PI(4,5)P2-specific allele of TIRAP
is sufficient to support TLR4 signaling is consistent with this idea.
However, PI(4,5)P2-specific alleles of TIRAP cannot support
TLR9 signaling. These observations argue strongly that the role
of TIRAP in TLR signaling from endosomes involves interactions
with lipids other than PI(4,5)P2. Our functional analysis of TIRAP
alleles that bind to single lipids revealed that PI(3)P and PS are
sufficient to support TLR9 signaling. From these data, it
becomes clear that multiple targets of the lipid-binding domain
of TIRAP are functionally important.
The analysis of TIRAP alleles that bind single lipids was also
informative in considering the precise subcellular sites of TLR
signaling. We found that PI(4,5)P2-specific and PS-specific
alleles of TIRAP are localized to the plasma membrane, but
only PI(4,5)P2 specificity confers LPS responsiveness. Because
the PS-specific TIRAP allele is functional when the correct stim-
ulus is applied to the cells (CpG DNA), these data cannot be ex-
plained by this protein being misfolded or poorly expressed.
Rather, these findings may highlight the precise requirement
for TIRAP to be present in a region of the cell surface that is
devoid of PS (or at least enriched for PI(4,5)P2). This suggestion
is consistent with prior work demonstrating that localization of
TIRAP to the plasma membrane is not sufficient for TLR4
signaling (Kagan andMedzhitov, 2006); TIRAPmust be localized
to PI(4,5)P2-rich regions specifically. Likewise, our analysis of
TLR9 signaling highlights the importance of TIRAP localization
to endosomes containing PS, the 30 PI PI(3)P, and probably
PI(3,5)P2 (Sasai et al., 2010). These observations are of note
when considering that the various membrane-bound organelles
in mammalian cells have been proposed to consist of a PI code
(Kutateladze, 2010). This PI code is ‘‘read’’ by various lipid-bind-
ing proteins to assemble different protein structures on different
membranes, effectively allowing the PI code to determine (in
part) the activities of each organelle (Kutateladze, 2010). Our
analysis of this PI code, through the use of TIRAP alleles that
bind to single lipids, provides a functional means to identify the
precise subcellular sites of TLR signal transduction. We suggest
that a comprehensive map of the sites of innate immune signal
transduction can be created by further study of the link between
the PI code and sorting adaptor localization.
From a broader perspective, this function for TIRAP in control-
ling TLR signaling from multiple organelles is reminiscent of the
activities of the protein MAVS, the receptor-proximal adaptorin the antiviral RIG-I like receptor signaling pathway (Seth
et al., 2005). Both MAVS and TIRAP can be considered sorting
adaptors, in that they define the subcellular sites of signal trans-
duction induced by their respective upstream receptors. Like
TIRAP, MAVS is located on several organelles in the cell, all of
which are important for antiviral signal transduction (Dixit et al.,
2010; Horner et al., 2011; Seth et al., 2005). Thus, a common
theme appears to be emerging whereby the sites of innate
immune signal transduction can be diversified simply by altering
the subcellular sites of sorting adaptor residence.
In summary, we have revealed a means by which a promiscu-
ous lipid-binding protein can be used in nature. We suggest that
the sorting adaptor TIRAP evolved specifically to survey multiple
organelles for the presence of activated TLRs. In this context, the
promiscuity of lipid binding by TIRAP provides a molecular
explanation for how the subcellular sites of TLR signal transduc-
tion are so diverse. Our work also demonstrates a means by
which functional diversity can be achieved at the level of a single
protein because TIRAP can now be considered to function in
bacterial detection at the plasma membrane and virus detection
in endosomes. These studies therefore highlight how pro-
miscuity, rather than specificity, can be beneficial in biological
systems, and provide amandate to examine the function of other
promiscuous lipid-binding proteins in the innate immune system,
and beyond.
EXPERIMENTAL PROCEDURES
Cell Culture, Stable Transductions, and Microscopy
All experiments with mice were performed with oversight by the appropriate
institutional review board to conform with approved animal protocols. WT
(C57B/6) and TIRAP KO iBMDMs were a gift from D. Golenbock (University
of Massachusetts) and were cultured in complete DMEM (GIBCO) containing
10% FBS and 5% L929 conditioned supernatant. Primary BMDMs from WT
(C57B/6) or TIRAP KO mice (Jax 017629) were prepared as described (Kagan
andMedzhitov, 2006). Cells were stimulated with LPS (Invitrogen) at 100 ng/ml
or phosphorothioate-linked CpG DNA (TCCATGACGTTCCTGACGTT; MWG
Operon) at 1 mM, unless otherwise indicated.
TIRAP alleles were introduced into TIRAP KO iBMDMs by retroviral trans-
duction and subjected to FACS to normalize GFP expression. When biotin-
based myddosome isolations were performed, TIRAP alleles were introduced
in iBMDMs stably expressing the biotin ligase BirA. Where indicated, cells
were fixed with 2% paraformaldehyde and stained with anti-GFP (Clontech)
according to manufacturer’s instructions. Antibody staining was detected
with the secondary antibody labeled with Alexa Fluor 488 and analyzed by
confocal microscopy.
Primary BMDMs were transfected by nucleofection using mouse macro-
phage transfection reagent (Lonza VPA-1009) according to manufacturer’s
instructions. Cells were imaged 4 hr later by confocal microscopy. Where indi-
cated, dextran-Alexa Fluor 647 (Life Technologies) was used at 10 mg/ml.
Flt3 Ligand-Induced Bone-Marrow-Derived pDC Culture
Bone marrow cells were isolated and cultured for 7 days in RPMI supple-
mented with 10% FBS, 50 U/ml penicillin, 50 mg/ml streptomycin, 10 mM
HEPES (Invitrogen), 2-mercaptoethanol (Sigma-Aldrich), and 100 ng/ml Flt3
ligand (GEMINI). On day 8, cells in the supernatant were harvested, counted,
and plated for subsequent experiments.
Viral Infections
KOS A, KOS CE, and KOS K (Sato et al., 2006) viruses were propagated and
titered on Vero cells as described (Knipe and Spang, 1982). The ICP0 null
(7134) and restored (7134R) virus was grown and titered on U2OS cells (Cai
and Schaffer, 1989). Virus was diluted in PBS containing 0.1% (w/v) glucoseCell 156, 705–716, February 13, 2014 ª2014 Elsevier Inc. 713
and 1% (v/v) heat-inactivated FBS. Cells were infected at the moi indicated for
1 hr at 37C, washed twice with PBS, and overlaid with DMEM containing 1%
(v/v) heat-inactivated FBS. Infected cells were incubated at 37C for the
indicated length of time. A total of 2 3 106/well pDCs were stimulated with
either 2 3 106 pfu (plaque-forming unit) of HSV-2 (186 syn+) or 2 3 107 pfu
of Influenza A/PR/8 for 24 hr. Supernatant was then harvested, and ELISA
was performed to measure IFNa and IL-12p40. BMDMs were infected with
the type 3 Dearing strain of reovirus at moi 10, 100, or 1,000 for 3 hr and
analyzed by quantitative PCR (qPCR) as described below.
Microarray Sample Generation, Data Acquisition, and Processing
pDC and cDC samples for microarrays were generated as described by
Iparraguirre et al. (2008). In brief, DPE-GFP 3 RAG1/ transgenic mice
(Mempel et al., 2006; Mrass et al., 2006), in which pDCs are identified by
GFP expression (Iparraguirre et al., 2008), were injected with Flt 3 ligand-
expressing B16F10 tumor cells for expansion of DC subsets. At 12–14 days
later, spleens were harvested and stained for CD11b and CD11c. pDCs and
cDCs were sorted using a MoFlo cell sorter (DakoCytomation) based on
high GFP expression and a CD11chiCD11bhi phenotype, respectively. Sam-
ples were prepared in two independent experiments. Total RNA, isolated
with the RNeasy kit (QIAGEN), was processed, amplified, labeled, and hybrid-
ized to mouseMOE430v2 GeneChip microarrays (Affymetrix) by the University
of Pennsylvania Microarray Core Facility using standard protocols. Data were
processed using Affymetrix GeneChip Operating System v.1.4 software, and
probe intensity files (.cel files) were imported and analyzed in Partek Genomics
Suite (v.6.6, Partek). Data were log2 transformed and normalized with GC
Robust Multi-array Averaging (GCRMA). Significance Analysis of Microarrays
([SAM] samr v.2.0; Stanford University) (Tusher et al., 2001) was applied to
identify differentially expressed genes in mature DCs (mDCs) and pDCs. The
most significant probe set for each gene of interest was used to calculate
fold changes (in Partek) between gene expression levels in mDCs versus
pDCs that were graphed using Prism software (v.5.0c; GraphPad Software).
Phagocytosis Assay
A total of 53 105 cells were kept on ice in 500 ml of complete media (described
above) and incubated with Fluoresbrite Carboxy YG 2.0 mm beads
(PolySciences) at ten beads/cell. Cells were added to a 37C water bath for
indicated times. Phagocytosis was stopped with ice-cold PBS. Cells were
washed 33 with ice-cold PBS and analyzed by FACS.
Myddosome Isolation Assay
Cells were plated on 10 cm tissue culture-treated dishes and grown to conflu-
ency (107 cells/plate overnight). Cells were stimulated with ligand as indicated,
then lysed in 700 ml of buffer containing 1% NP-40, 50 mM Tris-HCl (pH 7.4),
150 mM NaCl, 10% glycerol, and protease/phosphatase inhibitors (Roche).
A total of 100 ml of cleared lysate was retained for analysis (input), and the
remaining 600 ml was incubated overnight at 4C with 1 mg anti-MyD88 (R&D
LifeSciences) or anti-iRAK2 (ProSci). The following day, 50 ml of protein G
Sepharose (GE Healthcare) was added for 1 hr. Alternatively, cleared lysates
were incubated with NeutrAvidin agarose beads (Thermo Scientific) for 2 hr.
Beads were washed 33 with lysis buffer, then proteins were extracted by
adding 50 ml 2x Laemmli buffer, electrophoresed, and immunoblotted with
the indicated antibodies using standard conditions. The following antibodies
were used: anti-MyD88 (R&D LifeSciences), anti-iRAK2 (ProSci), anti-HA
(3F10; Roche), anti-GFP (JL-8; Clontech), and anti-actin (ac-15; Sigma-
Aldrich). Anti-iRAK4 was kindly provided by Shizuo Akira.
Real-Time qPCR
Total RNA was extracted from 23 106 cells using RNA-Bee (Tel-Test) accord-
ing to manufacturer’s instructions and analyzed with TaqMan one-step qPCR
reagents. Expression was plotted relative to GAPDH, shown as mean and SD
of three technical replicates. All qPCRgraphs in this study are representative of
at least three independent experiments.
Plasmids
TIRAP-TAP IRES GFPwas produced as follows. Human TIRAPwas appended
with triple HA and a BirA target site (de Boer et al., 2003; Mechold et al., 2005)714 Cell 156, 705–716, February 13, 2014 ª2014 Elsevier Inc.by overlap extension PCR. The biotin ligase BirA (Mechold et al., 2005) was
subcloned into pMSCV2.2 by standard procedures. WT TIRAP-GFP, PLC-
TIRAP-GFP, and PX-TIRAP-GFP were described previously (Kagan and
Medzhitov, 2006) and are present in the retroviral vector MSCV202 IRES-
hCD2. pEGFP-N1-based TIRAP loc-GFP (amino acids 1–85 of TIRAP fused
in frame to GFP) was described previously (Kagan and Medzhitov, 2006).
SLP2a-TIRAP-GFP was cloned similarly to the TIRAP alleles described above.
Briefly, the C2A domain of murine SLP2a was cloned from a murine spleen
cDNA library and fused in frame to amino acid 86 of TIRAP-GFP. This
SLP2a-TIRAP-GFP fusion cDNA was then subcloned into the retroviral vector
MSCV2.2 IRES-hCD2. mCherry-PH was purchased from Addgene (plasmid
36075).ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the microarray
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